By rray, 12 July, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text In the context of shared decision making clinicians may offer noninvasive therapies pharmacotherapy or minimally invasive therapies EO nbsp nbsp If OAB predominant LUTS bladder outlet reduction surgeries e g transurethral resection HoLEP or photovaporizat If pt chooses pharmacotherapy offer monotherapy w antimuscarinic or 3 agonist or combo tx w an blocker an antimuscarinic or 3 agonist CR B nbsp nbsp If OAB predominant LUTS Assess relative contribution of BOO secondary to BPH Evaluate presence and severit Patient Type Detail Header (Long) Comorbid benign prostatic hyperplasia